Across TCGA pan-cancer cohorts, ZNF587P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ZNF587P1’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where ZNF587P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF587P1 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

ESCA, LUSC, and THCA are the cancer types where ZNF587P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF587P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	II,III,IV	+1.030	.012	2	view →
LUSC	Female	All	−0.057	.003	2	view →
THCA	Female	II,III,IV	−0.042	.036	2	view →
STAD	All	All	+0.256	.027	1	view →
KICH	All	All	−0.020	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: ZNF587P1 RNA expression & survival · all ZNF587P1 data types